90411-17-9Relevant articles and documents
Discovery of kynurenines containing oligopeptides as potent opioid receptor agonists
Benyhe, Sándor,Dimmito, Marilisa Pia,Mollica, Adriano,Nalli, Marianna,Pieretti, Stefano,Stefanucci, Azzurra,Sz?cs, Edina,Vécsei, László,Zádor, Ferenc,Zengin, Gokhan
, (2020)
Kynurenine (kyn) and kynurenic acid (kyna) are well-defined metabolites of tryptophan catabolism collectively known as “kynurenines”, which exert regulatory functions in host-microbiome signaling, immune cell response, and neuronal excitability. Kynurenine containing peptides endowed with opioid receptor activity have been isolated from natural organisms; thus, in this work, novel opioid peptide analogs incorporating L-kynurenine (L-kyn) and kynurenic acid (kyna) in place of native amino acids have been designed and synthesized with the aim to investigate the biological effect of these modifications. The kyna-containing peptide (KA1) binds selectively the μ-opioid receptor with a Ki = 1.08 ± 0.26 (selectivity ratio μ/δ/? = 1:514:10000), while the L-kyn-containing peptide (K6) shows a mixed binding affinity for μ, δ, and ?-opioid receptors, with efficacy and potency (Emax = 209.7 + 3.4%; LogEC50 = ?5.984 + 0.054) higher than those of the reference compound DAMGO. This novel oligopeptide exhibits a strong antinociceptive effect after i.c.v. and s.c. administrations in in vivo tests, according to good stability in human plasma (t1/2 = 47 min).
Kynurenic acid derivatives, their preparation and pharmaceutical compositions containing them
-
, (2008/06/13)
Kynurenic acid derivatives useful as therapeutic agents in treating neurological disorders, for example, thiokynurenic acid, 7-chloro-thio-kynurenic acid, 7-trifluoromethyl-thiokynurenic acid, 7-methoxy-thiokynurenic acid and 5-fluoro-thiokynurenic acid.
